209 related articles for article (PubMed ID: 10207103)
1. hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.
Germani A; Romero F; Houlard M; Camonis J; Gisselbrecht S; Fischer S; Varin-Blank N
Mol Cell Biol; 1999 May; 19(5):3798-807. PubMed ID: 10207103
[TBL] [Abstract][Full Text] [Related]
2. A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK.
Yablonski D; Kane LP; Qian D; Weiss A
EMBO J; 1998 Oct; 17(19):5647-57. PubMed ID: 9755165
[TBL] [Abstract][Full Text] [Related]
3. Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter.
Kaminuma O; Deckert M; Elly C; Liu YC; Altman A
Mol Cell Biol; 2001 May; 21(9):3126-36. PubMed ID: 11287617
[TBL] [Abstract][Full Text] [Related]
4. Vav-induced activation of the human IFN-gamma gene promoter is mediated by upregulation of AP-1 activity.
Kaminuma O; Elly C; Tanaka Y; Mori A; Liu YC; Altman A; Miyatake S
FEBS Lett; 2002 Mar; 514(2-3):153-8. PubMed ID: 11943142
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line.
Cao Y; Janssen EM; Duncan AW; Altman A; Billadeau DD; Abraham RT
EMBO J; 2002 Sep; 21(18):4809-19. PubMed ID: 12234921
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
7. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor.
Foucault I; Le Bras S; Charvet C; Moon C; Altman A; Deckert M
Blood; 2005 Feb; 105(3):1106-13. PubMed ID: 15345594
[TBL] [Abstract][Full Text] [Related]
8. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
9. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.
Salojin KV; Zhang J; Delovitch TL
J Immunol; 1999 Jul; 163(2):844-53. PubMed ID: 10395678
[TBL] [Abstract][Full Text] [Related]
10. A functional T-cell receptor signaling pathway is required for p95vav activity.
Wu J; Katzav S; Weiss A
Mol Cell Biol; 1995 Aug; 15(8):4337-46. PubMed ID: 7623828
[TBL] [Abstract][Full Text] [Related]
11. Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes.
Doody GM; Billadeau DD; Clayton E; Hutchings A; Berland R; McAdam S; Leibson PJ; Turner M
EMBO J; 2000 Nov; 19(22):6173-84. PubMed ID: 11080163
[TBL] [Abstract][Full Text] [Related]
12. Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte.
Tartare-Deckert S; Monthouel MN; Charvet C; Foucault I; Van Obberghen E; Bernard A; Altman A; Deckert M
J Biol Chem; 2001 Jun; 276(24):20849-57. PubMed ID: 11262396
[TBL] [Abstract][Full Text] [Related]
13. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity.
Billadeau DD; Mackie SM; Schoon RA; Leibson PJ
J Exp Med; 2000 Aug; 192(3):381-92. PubMed ID: 10934226
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of the vav proto-oncogene product links FcepsilonRI to the Rac1-JNK pathway.
Teramoto H; Salem P; Robbins KC; Bustelo XR; Gutkind JS
J Biol Chem; 1997 Apr; 272(16):10751-5. PubMed ID: 9099726
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of T cell antigen receptor-induced Erk2 kinase activation in Lck-negative JCaM1 cells by Syk.
Williams S; Couture C; Gilman J; Jascur T; Deckert M; Altman A; Mustelin T
Eur J Biochem; 1997 Apr; 245(1):84-90. PubMed ID: 9128727
[TBL] [Abstract][Full Text] [Related]
16. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
[TBL] [Abstract][Full Text] [Related]
17. Specific subdomains of Vav differentially affect T cell and NK cell activation.
Billadeau DD; Mackie SM; Schoon RA; Leibson PJ
J Immunol; 2000 Apr; 164(8):3971-81. PubMed ID: 10754287
[TBL] [Abstract][Full Text] [Related]
18. Vav modulation of the Ras/MEK/ERK signaling pathway plays a role in NFAT activation and CD69 up-regulation.
Villalba M; Hernandez J; Deckert M; Tanaka Y; Altman A
Eur J Immunol; 2000 Jun; 30(6):1587-96. PubMed ID: 10898494
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
[TBL] [Abstract][Full Text] [Related]
20. Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells.
Lindholm CK; Henriksson ML; Hallberg B; Welsh M
Eur J Biochem; 2002 Jul; 269(13):3279-88. PubMed ID: 12084069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
